China Newsbase
Fast, easy search of the China news that matters
The China News Database was last updated at 01:50PM on November 9, 2023.
Database searches currently perform best when a tag filter is used. We suggest trying out these tags: Xi Jinping, Russia, Taiwan, COVID-19, climate change, electric vehicles, gaming, IPOs, Belt and Road Initiative.
You may also filter by articles featured in our daily members-only Access newsletter, to get a curated overview of the top news and analysis about Chinese politics, business, and society. Select one option:
- All top news and analysis
- The China Project top news and analysis
- Top news and analysis from elsewhere — Stories in the “News briefing,” previously known as “Recommended links”
This product is in beta testing and development. If you would like to share feedback on the content or user experience, please email editors@thechinaproject.com.
209 articles matching the search query.
China says will vaccinate 'key groups' over winter, spring
China will focus first on vaccinating high-risk groups over the winter and spring before widening the inoculation to the general public, a senior health official said on Saturday.
China to Vaccinate 50 Million People With Its Covid-19 Shots
China is expanding an already considerable rollout of its leading Covid-19 vaccine candidates.
After US, when will Asia get COVID-19 vaccines? 5 things to know
Pfizer inoculations proceed in West while other countries to wait months
China gave COVID-19 vaccine candidate to North Korea's Kim: U.S. analyst
(This story corrects identity and removes RIC of third company listed in para 5 to China Pharmaceutical Group (Sinopharm), and in para 6 corrects to show Phase 3 trials being conducted outside China)
BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China
BioNTech and Shanghai Fosun Pharmaceutical said on Wednesday they would launch a Phase II clinical trial of BioNTech's experimental COVID-19 vaccine in China.
China gives pledge on access for COVID origins probe: WHO
The World Health Organization (WHO) has had assurances from China that an international field trip to investigate the origins of the new coronavirus will be arranged as soon as possible, its top emergency expert said on Monday.
Hungary could receive up to one million doses of Chinese coronavirus vaccine: foreign minister
Hungary could receive up to one million doses of coronavirus vaccine from China in the coming months, Foreign Minister Peter Szijjarto told state news agency MTI on Friday after a phone call with his Chinese counterpart.
Turkey to buy Chinese COVID-19 candidate vaccine doses, in talks with Pfizer
Turkey will sign a contract within days to buy at least 20 million doses of a COVID-19 candidate vaccine from China's Sinovac Biotech, the health minister was cited as saying, adding that Ankara was also in talks to buy doses of Pfizer and BioNTech's vaccine.
Italian study suggesting COVID predates China outbreak sparks scepticism
An Italian study supporting the case that the novel coronavirus was circulating outside China earlier than thought has sparked doubts among some Western scientists who called for further tests.
Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate
Brazil's Sao Paulo state is set to begin importing the first of 46 million doses of China's Sinovac vaccine against COVID-19 this week, while the federal government takes a more cautious approach with a vaccine developed by Pfizer Inc.
West China Hospital's COVID-19 vaccine candidate enters mid-stage human trial
An experimental coronavirus vaccine developed by West China Hospital has entered a mid-stage human test, authorities of China's southwestern province of Sichuan said on Tuesday.
China's Rhodiola set to sell and test Russia's Sputnik-V vaccine
China's Tibet Rhodiola Pharmaceutical Holding announced a deal on Wednesday to manufacture, sell and test Russia's COVID-19 vaccine in China, hours after interim results showed it was 92% effective at protecting people from the disease.
China's Sinopharm says data 'better than expected" from unit's COVID-19 vaccine trials
China National Pharmaceutical Group (Sinopharm) said on Wednesday the data from large-scale, late-stage clinical trials for its unit's COVID-19 vaccine are "better than expected".
Uzbekistan to carry out late-stage trial of Chinese COVID-19 vaccine candidate
Uzbekistan will carry out a phase III trial of a coronavirus vaccine candidate developed by China's Anhui Zhifei Longcom Biopharmaceutical Co., the Central Asian nation's ministry of innovative development told Reuters on Wednesday.
Sao Paulo starts building production plant for China's Sinovac vaccine: governor
The Brazilian state of São Paulo has begun building a facility to produce 100 million doses a year of China's Sinovac vaccine against COVID-19, which will be ready by September next year, Governor João Doria said on Monday.
AstraZeneca's COVID-19 vaccine to begin clinical trials in China - executive
AstraZeneca Plc plans to start early and mid-stage clinical trials of its COVID-19 vaccine candidate in China this year, a senior executive said on Friday, as it prepares a global rollout of the vaccine.
China's Fosun to seek approval for BioNTech's COVID-19 second vaccine, ends trials on first
BioNTech's Chinese partner Shanghai Fosun Pharmaceutical Group does not plan to run further clinical trials of the German firm's coronavirus vaccine candidate that has completed early-stage trials in China, an executive said.
Brazil will buy China COVID-19 vaccine, VP Mourão says, contradicting Bolsonaro
Brazil's government will "of course" buy a Chinese COVID-19 vaccine that is being tested in the country, Vice President Hamilton Mourão said on Friday, in the latest example of him contradicting President Jair Bolsonaro.
Organised 'overkill': China shows off rapid lockdown system after latest outbreak
Days after a 17-year-old girl tested positive for COVID-19 in a remote part of western China last week, health authorities said they had tested over 4.7 million people in the region.
Covid-19 Vaccine Makers See Egypt as Crucial Launchpad
With a population of nearly 100 million and an established vaccine-manufacturing capacity, Egypt is emerging as a critical proving ground for global powers seeking to export a vaccine to the developing world.
